PharmAthene, Inc. (ALT)

Last Three Months

21-Jan-24 -- 20-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Diversified Investments

Financial Services

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

34

0

5

+1

0

+2

0

+3

Two Year Chart

21-Apr-22 -- 20-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Feb-24 6:02 PM View:	02-Feb-24 Payment of Exercise ($21.72K)	Roberts M Scot Chief Scientific Officer		PharmAthene, Inc. - ALT	109% 20.44K to 42.67K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 6:00 PM View:	02-Feb-24 Payment of Exercise ($78.06K)	Garg Vipin K President and CEO Director		PharmAthene, Inc. - ALT	17% 249.25K to 292.03K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 6:01 PM View:	02-Feb-24 Payment of Exercise ($21.73K)	Harris Matthew Scott Chief Medical Officer		PharmAthene, Inc. - ALT	58% 34.0K to 53.63K	0	0	--	--	Show Txns Hide Txns

01-Feb-24 6:00 PM View:	31-Jan-24 Grant $12.43K	Eisenstadt Richard I Chief Financial Officer		PharmAthene, Inc. - ALT	35% 33.29K to 45.01K	0	0	--	--	Show Txns Hide Txns

01-Feb-24 6:02 PM View:	31-Jan-24 Grant $13.53K	Jordt Raymond M Chief Business Officer		PharmAthene, Inc. - ALT	58% 8.71K to 13.74K	0	0	--	--	Show Txns Hide Txns